Bortezomib in kidney transplantation. - Wikidata - awgldk - TriplyDB

Bortezomib in kidney transplantation.

Bortezomib in kidney transplantation.

http://www.wikidata.org/entity/Q34189435

about

Current state of renal transplant immunosuppression: Present and future B Cells, Antibodies, and More.Exploiting nature's rich source of proteasome inhibitors as starting points in drug development.The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection.Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development.Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future.Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome.A Case of Alport Syndrome with Posttransplant Antiglomerular Basement Membrane Disease despite Negative Antiglomerular Basement Membrane Antibodies by EIA Treated with Plasmapheresis and Intravenous Immunoglobulin.Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.

P2860

Q26829789-173669F1-DACC-4692-8536-CD6F148EE99E Q36432935-352EECC8-EC59-42A9-96E5-40045DC51450 Q37951013-E88AE6AD-6A6A-461F-A823-D5D9EFAADE2F Q37992871-6801D4FD-979A-4B41-B550-266F9BD1FFE0 Q38019864-71190A4E-EA06-4E8F-90ED-B35C288D9EC8 Q38676578-60D1CF17-08F7-4512-979F-D3CBA40E547B Q39782329-7BCF113A-5B77-4AA6-BF25-8582E3E68EF0 Q42789800-F7EA5400-4F08-42A4-BE07-5CF6F5FCEF51 Q47119070-8AC3E38E-047F-469F-97CE-F9A9B9834C51 Q49181404-CF38F4C8-4DE9-4221-88F0-FF0089199A5B

P2860

Bortezomib in kidney transplantation.

http://www.wikidata.org/entity/Q34189435

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Bortezomib in kidney transplantation.

@ast

Bortezomib in kidney transplantation.

@en

Bortezomib in kidney transplantation.

@nl

type

label

Bortezomib in kidney transplantation.

@ast

Bortezomib in kidney transplantation.

@en

Bortezomib in kidney transplantation.

@nl

prefLabel

Bortezomib in kidney transplantation.

@ast

Bortezomib in kidney transplantation.

@en

Bortezomib in kidney transplantation.

@nl

P1433

Q34189435-ECF6CF5D-7EA2-4041-9F36-9D09076D94EF

P1476

Q34189435-2135D493-9389-457A-AF4D-269583C43050

P2093

Q34189435-3021ABA0-5D54-4ED2-B618-9DB84F93589C

Q34189435-31797645-1E80-450A-9EA1-A1A0541023EE

Q34189435-6E72A165-8CE9-41F4-965D-5988556BBDFD

Q34189435-88D3CF11-E3C2-4D32-9171-DF989DC6C81C

Q34189435-B78D0CF4-F1AD-4180-A72D-5F8A78462604

Q34189435-F84BB155-C52E-4F32-A714-0EF8453F732D

P2860

Q34189435-073C6086-B002-4F7D-90C5-3F5A5F516858

Q34189435-301FDC6F-2750-492D-B4F9-1F6C327831E0

Q34189435-31278684-7DAA-46A1-AA94-F7200E41DF3C

Q34189435-39E2F01B-7512-425E-9C21-FD35DBC7703D

Q34189435-40D0F7C9-25AB-44E1-8A07-C2C1BDF37259

Q34189435-470B8302-5145-4733-9A5D-16140A8D695F

Q34189435-52A56F58-E4C1-4738-BC16-151031E5F7B7

Q34189435-60288977-C872-4798-86C8-F87A86747369

Q34189435-65E208F1-2069-4BA0-A2C4-86E5365B9BA4

Q34189435-69E79A4F-4A22-4687-9648-71FFA447C66C

P304

Q34189435-AD238969-0B03-452D-A860-6E7AF5005B99

P31

Q34189435-B3A6BD67-7A3C-4E3C-A169-F8583D66A5D8

P356

Q34189435-8012FB00-4D83-4562-804F-4C48D83E497E

P478

Q34189435-BF303F9D-5380-491D-9073-25B3B04F9B3B

P577

Q34189435-15AC5C1D-7333-45AA-8E27-9E2E34706E39

P5875

Q34189435-56E49A05-5268-415D-9E0A-808F6C841EBE

P698

Q34189435-F0FFC89E-8EF5-4698-BC5D-67F4B2F37778

P932

Q34189435-D81D195B-A8CD-4450-BF34-69CC17CB5EAA

P356

P1433

Journal of transplantation

P1476

Bortezomib in kidney transplantation.

@en

P2093

A Osama Gaber

http://www.w3.org/2001/XMLSchema#string

Abdallah Jeroudi

http://www.w3.org/2001/XMLSchema#string

Abdul Abdellatif

http://www.w3.org/2001/XMLSchema#string

Katafan Achkar

http://www.w3.org/2001/XMLSchema#string

Rajeev Raghavan

http://www.w3.org/2001/XMLSchema#string

Samir J Patel

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Abrogation of anti-HLA antibodies via proteasome inhibition.

The proteasome as a target for cancer therapy.

Ascorbic acid inhibits antitumor activity of bortezomib in vivo.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications.

Humoral theory of transplantation.

Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma.

P304

104-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/698594

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47450635

http://www.w3.org/2001/XMLSchema#string

P698

20953363

http://www.w3.org/2001/XMLSchema#string

P932

2952895

http://www.w3.org/2001/XMLSchema#string